Literature DB >> 33112584

CORR Insights®: Proximal Humerus Tumors: Higher-than-Expected Risk of Revision With Constrained Reverse Shoulder Arthroplasty.

Gerhard E Maale1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33112584      PMCID： PMC7571933          DOI： 10.1097/CORR.0000000000001308

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  6 in total

1.  Effect of humeral component version on impingement in reverse total shoulder arthroplasty.

Authors:  Daniel R Stephenson; Joo Han Oh; Michelle H McGarry; George F Rick Hatch; Thay Q Lee
Journal:  J Shoulder Elbow Surg       Date:  2010-12-08       Impact factor: 3.019

Review 2.  Fabrication methods of porous metals for use in orthopaedic applications.

Authors:  Garrett Ryan; Abhay Pandit; Dimitrios Panagiotis Apatsidis
Journal:  Biomaterials       Date:  2006-01-19       Impact factor: 12.479

3.  Reconstruction with constrained scapular prosthesis after total scapulectomy for scapular malignant tumor.

Authors:  Baichuan Wang; Qiang Wu; Zhicai Zhang; Jianxiang Liu; Zengwu Shao
Journal:  J Surg Oncol       Date:  2018-06-07       Impact factor: 3.454

4.  Constrained fixed-fulcrum reverse shoulder arthroplasty improves functional outcome in epileptic patients with recurrent shoulder instability.

Authors:  Tanujan Thangarajah; Deborah Higgs; J I L Bayley; Simon M Lambert
Journal:  World J Orthop       Date:  2016-07-18

5.  A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.

Authors:  W F Enneking; W Dunham; M C Gebhardt; M Malawar; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1993-01       Impact factor: 4.176

6.  Proximal Humerus Tumors: Higher-than-Expected Risk of Revision With Constrained Reverse Shoulder Arthroplasty.

Authors:  Mehmet Ayvaz; Riza Mert Cetik; Sancar Bakircioglu; A Mazhar Tokgozoglu
Journal:  Clin Orthop Relat Res       Date:  2020-11       Impact factor: 4.755
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.